Gilead Sciences Inc
(GILD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,965,000 | 7,417,000 | 10,635,000 | 10,027,000 | 6,209,060 |
| Marketable Securities | 1,749,000 | 1,194,000 | 659,000 | 101,000 | 107,266 |
| Receivables | 6,105,000 | 5,331,000 | 4,835,000 | 4,635,000 | 2,850,367 |
| Inventories | 1,988,000 | 2,039,000 | 1,908,000 | 1,386,000 | 1,909,584 |
| Income taxes - deferred | 894,000 | 833,000 | 655,000 | 508,000 | 384,588 |
| Other current assets | 0 | 553,000 | 761,000 | 0 | 267,246 |
| TOTAL | $25,910,000 | $18,093,000 | $20,062,000 | $17,714,000 | $12,562,030 |
| Non-Current Assets | |||||
| PPE Net | 2,143,000 | 1,899,000 | 1,765,000 | 1,674,000 | 1,509,796 |
| Investments And Advances | 9,400,000 | 6,056,000 | 3,220,000 | 1,598,000 | 1,375,400 |
| Intangibles | 11,626,000 | 11,832,000 | 12,039,000 | 12,245,000 | 12,478,111 |
| Other Non-Current Assets | 1,558,000 | 1,287,000 | 1,235,000 | 1,433,000 | 919,053 |
| TOTAL | $24,727,000 | $21,074,000 | $18,259,000 | $16,950,000 | $16,282,360 |
| Total Assets | $50,637,000 | $39,167,000 | $38,321,000 | $34,664,000 | $28,844,390 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 331,000 | 352,000 | 442,000 | 483,000 | 1,477,082 |
| Accounts payable and accrued liabilities | 1,239,000 | 1,571,000 | 1,011,000 | 955,000 | 1,182,917 |
| Accrued Expenses | 4,713,000 | 4,635,000 | 4,246,000 | 2,316,000 | 2,009,428 |
| TOTAL | $9,360,000 | $8,925,000 | $7,428,000 | $5,761,000 | $6,054,952 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,272,000 | 12,682,000 | 12,540,000 | 12,507,000 | 8,415,582 |
| Deferred Revenues | 356,000 | 501,000 | 191,000 | 134,000 | 116,880 |
| Other Non-Current Liabilities | 1,039,000 | 885,000 | 725,000 | 602,000 | 451,815 |
| TOTAL | $23,333,000 | $13,608,000 | $13,305,000 | $13,084,000 | $8,925,830 |
| Total Liabilities | $32,693,000 | $22,533,000 | $20,733,000 | $18,845,000 | $14,980,780 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,441,180 | 1,467,606 | 1,469,606 | 1,489,402 | 1,508,664 |
| Common Shares | 1,000 | 2,000 | 1,000 | 2,000 | 1,514 |
| Retained earnings | 16,961,000 | 16,038,000 | 13,916,000 | 12,732,000 | 11,247,660 |
| Other shareholders' equity | 697,000 | 594,000 | 947,000 | 694,000 | 471,344 |
| TOTAL | $17,944,000 | $16,634,000 | $17,588,000 | $15,819,000 | $13,863,610 |
| Total Liabilities And Equity | $50,637,000 | $39,167,000 | $38,321,000 | $34,664,000 | $28,844,390 |